dg health clearlax
NDC 55910-846, Polyethylene Glycol 3350, powder, for solution, from Dolgencorp Inc.
- Product NDC
- 55910-846
- Status
- Listed
- Labeler
- Dolgencorp Inc
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA090685
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55910-846 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 335017 g/17g
Pharmacologic classes
Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55910-846-02 | 55910084602 | 238 g in 1 BOTTLE (55910-846-02) |
| 55910-846-03 | 55910084603 | 510 g in 1 BOTTLE (55910-846-03) |
| 55910-846-04 | 55910084604 | 119 g in 1 BOTTLE (55910-846-04) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55910-846 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55910-846 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55910-846. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.